Dr Reddy’s can make Novo’s weight loss drug, rules HC
NEW DELHI: In a significant development in the blockbuster weight loss drug space, Delhi High Court has allowed Dr Reddy’s Labs to manufacture and export semaglutide, ruling that the patent held by Novo Nordisk is prima facie invalid, legal experts told TOI.The move is expected to boost confidence among domestic companies to pursue plans to…